Mistake 3: ignoring the B12 component Some people treat the B12 in their compounded formulation as irrelevant window dressing
If your primary goal is maximum weight loss and you do not have a compelling reason to choose semaglutide, tirzepatides clinical data give it an edge
Any color change means something has gone wrong
If youve struggled with weight loss, youre not alone
In metabolic-related trials, Novo Nordisk leads the pack Speaking of Novo Nordisk, the company remains a leader in terms of GLP-1 clinical trials, with twice as many as the nearest competitor, Eli Lilly
Not a silver bullet: making nuanced decisions for each patient However, GLP-1RAs are not universally effective for all patients, and Yuan said that even after deciding to prescribe this drug class, physicians should consider multiple factors when selecting a specific drug and dosage